Franz Sesti

[European Society of Endocrinology (ESE) @ESEndocrinology]

Today is @netcancerday NETs are more common than brain, ovarian, or cervical cancer and incidence is on the rise.

Easily missed. Take a closer look at neuroendocrine cancer.
https://t.co/1Z9YMgckgJ

#BecauseHormonesMatter #LetsTalkAboutNETs #NETCancerDay

[European Academy of Andrology @EAAndrology]

Here Is professor @amisidori from Sapienza University of Rome with his talk on ultrasound imaging in testicular lesions!

[Isidori_Group @GroupIsidori]

Very proud to share our #ScienceResearch just released in @ScienceTM, co-first author @Riccardopofi and @Elisagiannetta, dealing with ‘Sex expectations’ in diabetic complications: men and women can get different beneficial effects from daily tadalafil!👇
https://t.co/QujmzpJkxU

[Frontiers - Oncology @FrontOncology]

New research: Sunitinib Treatment for Advanced Paraganglioma: Case Report of a Novel SDHD Gene Mutation Variant and Systematic Review of the Literature: Background Paragangliomas (PGLs) are neuroendocrine neoplasms arising from chromaffin cells… https://t.co/QWNet4efea #oncology

[Frontiers - Endocrinology @FrontEndocrinol]

New Research: Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers: Background Hypercalcemia is a common paraneoplastic syndrome which can occur in up to 10% of… https://t.co/LF1vBVJamj #Endocrinology #Endo

[Isidori_Group @GroupIsidori]

Terrific paper dealing with the pathophysiology of Diabetic Cardiomiopathy! Pleasant collaboration, great results, steps ahead on disease' recognition and treatment. well done @RiccardoPofi @JACCJournals #JACCIMG @RicercaSapienza @SapienzaRoma @SIE_2013
https://t.co/77xqKqhfBP

[MariannaMinnetti @minnetticon2N]

A comprehensive systematic review on Subclinical Male Hypogonadism
https://t.co/3FNqe27Lqp @GroupIsidori @SiamsWeb

[MariannaMinnetti @minnetticon2N]

Metabolic complications in #acromegaly after neurosurgery: A meta-analysis. @EJEndo https://t.co/THMGVvkZug @GroupIsidori

[Isidori_Group @GroupIsidori]

Out now! Well done @FranzSesti, this will definitely clarify the link between testosterone therapy and cardiovascular outcomes!

[MariannaMinnetti @minnetticon2N]

Late‐onset hypogonadism: reductio ad absurdum of the cardiovascular risk–benefit of testosterone replacement therapy https://t.co/wyrVjcCGve @GroupIsidori @EAAndrology

[Franz Sesti @FranzSesti]

Late‐onset hypogonadism: reductio ad absurdum of the cardiovascular risk–benefit of testosterone replacement therapy @GroupIsidori @EAAndrology https://t.co/9tlyrDXTlL

[Frontiers - Endocrinology @FrontEndocrinol]

New Research: Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature: Introduction: Laryngeal neuroendocrine neoplasms (NENs) are a rare group of… https://t.co/KQ2dzjw0tk #Endocrinology #Endo

[Franz Sesti @FranzSesti]

Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature @GroupIsidori @FrontEndocrinol https://t.co/yJguJg9KrK

[Isidori_Group @GroupIsidori]

Another strong rationale for PDE5i! Have a read! Well done @ElisaGiannetta
Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection https://t.co/zMwZkiNu3Y
@RicercaSapienza @EAAndrology @wileylibraries

[Franz Sesti @FranzSesti]

Testicular ultrasound (TU) score: a new proposal for a scoring system to predict testicular function https://t.co/j4wJEFksY3 @GroupIsidori

[Frontiers - Endocrinology @FrontEndocrinol]

New Research: A Novel MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors: Introduction: Pheochromocytomas (PCCs), paragangliomas (PGLs), ganglioneuroblastomas (GNBs), and… https://t.co/bbM83joLnf #Endocrinology #Endo

[Franz Sesti @FranzSesti]

A Novel MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors https://t.co/t1iTSEQ1Qo @FrontEndocrinol @GroupIsidori

[Isidori_Group @GroupIsidori]

Interesting new MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors. Well done @CarlottaPozza and @FranzSesti!
https://t.co/JiJ1tfKyX0

[Isidori_Group @GroupIsidori]

A new, cheap and non-invasive technique for LUTS treatment in benign prostatic hyperplasia! https://t.co/FGHf1nifeW

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

#Online: Use of #glucocorticoids in patients with #adrenal insufficiency and #COVID-19 infection. Read for FREE: https://t.co/ijcGaFxhxB #COVID19